ASCVD Incretin Switch Card

A point-of-care shared-decision tool for cardiologists and endocrinologists that turns the first head-to-head cardiovascular trial of tirzepatide versus dulaglutide into a concrete continue-or-switch recommendation for each patient with type 2 diabetes and established heart disease.